VPS4A Antibody

Category: Antibodies
Catalog
CSB-PA891974DSR2HU
(Ships in 5-10 business days)

Questions? Contact us

Call (800) 832-2611

arp-guarantee
- +
$0.00
More Information
Product Name VPS4A Antibody
Description Rabbit polyclonal antibody to VPS4A
Synonyms hVPS4 antibody; Protein SKD2 antibody; SKD1 antibody; SKD1 homolog antibody; SKD1A antibody; SKD2 antibody; Vacuolar protein sorting 4 homolog A antibody; Vacuolar protein sorting 4, yeast, homolog of, A antibody; Vacuolar protein sorting factor 4A antibody; Vacuolar protein sorting-associated protein 4A antibody; vacuolar sorting protein 4 antibody; VPS4 antibody; VPS4-1 antibody; Vps4a antibody; VPS4A_HUMAN antibody
Host Rabbit
Clonality Polyclonal
Conjugate Unconjugated
Immunogen Recombinant human Vacuolar protein sorting-associated protein 4A protein (1-120AA)
Isotype IgG
Target VPS4A
Reactivity Human, Mouse, Rat
Applications ELISA, IHC, WB
Form Liquid
Diluent Buffer PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Uniprot Q9UN37
Storage Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Background Involved in late steps of the endosomal multivesicular bodies (MVB) pathway. Recognizes membrane-associated ESCRT-III assemblies and catalyzes their disassembly, possibly in combination with membrane fission. Redistributes the ESCRT-III components to the cytoplasm for further rounds of MVB sorting. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. In conjunction with the ESCRT machinery also appears to function in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and enveloped virus budding (HIV-1 and other lentiviruses). Involved in cytokinesis: retained at the midbody by ZFYVE19/ANCHR and CHMP4C until abscission checkpoint signaling is terminated at late cytokinesis. It is then released following dephosphorylation of CHMP4C, leading to abscission (PubMed:24814515). VPS4A/B are required for the exosomal release of SDCBP, CD63 and syndecan (PubMed:22660413).
Supplier Cusabio

All Research Products are sold for laboratory RESEARCH USE ONLY and ARE NOT TO BE USED FOR HUMAN OR ANIMAL THERAPEUTIC OR DIAGNOSTIC APPLICATIONS. The information presented is believed to be accurate; however, said information and products are offered without warranty or guarantee since the ultimate conditions of use and the variability of the materials treated are beyond our control. Nothing disclosed herein is to be construed as a recommendation to use our products in violation of any patents. ARP American Research Products, Inc. does not submit its products for regulatory review by any government body or other organization, and we do not validate them for clinical, therapeutic or diagnostic use, or for safety and effectiveness. You are solely responsible for making sure that the way you use the products complies with applicable laws, regulations and governmental policies and for obtaining all necessary approvals, intellectual property rights, licenses and permissions that you may need related to your use. Under no circumstances shall ARP American Research Products, Inc. be liable for damages, whether consequential, compensatory, incidental or special, strict liability or negligence, breach of warranty or any other theory arising out of the use of the products available from ARP American Research Products, Inc. Nothing contained herein warrants that the use of the products will not infringe on the claims of any patents covering the product itself or the use thereof in combination with other products or in the operation of any process. ARP American Research Products, Inc. disclaims any and all representations or warranties of any kind whatsoever, express or implied, including without limitation any implied warranties of merchantability or fitness for a particular purpose, of non-infringement, or regarding results obtained through the use of any product, whether arising from a statute or otherwise in law or from a course of performance, dealing or usage of trade.